Aripiprazole is an atypical antipsychotic (APD) that is purported to act by serving as a partial agonist at the D2 receptor, instead of serving as an antagonist like other APDs. It is used to treat schizophrenia, major depression (as an adjunct to antidepressants) and bipolar disorder.
- NCBI Bookshelf provides free book resources on this topic.
- PubMed provides review articles from the past five years (limit to free review articles or to systematic reviews)
- The TRIP database provides clinical publications about evidence-based medicine.